Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 190 publications
Author Correction: SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: June 29, 2026
EPR26-163: The Epidemiology of Second Primary Lung Cancer: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Program.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
QIM26-303: An Innovative Team Approach to Standardize SCLC Care Delivery Across an Integrated Health System.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2026
HSR26-208: Disparities in Definitive Treatment for Older Adults With Early-Stage Non-Small Cell Lung Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026
EPR26-163: The Epidemiology of Second Primary Lung Cancer: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Program.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
HSR26-208: Disparities in Definitive Treatment for Older Adults With Early-Stage Non-Small Cell Lung Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 31, 2026
QIM26-303: An Innovative Team Approach to Standardize SCLC Care Delivery Across an Integrated Health System.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Phase 1 Trial of Withania somnifera Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [18F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials.
Journal: Integrative cancer therapies
Published: February 13, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Comprehensive Analysis of the Value of Dynamic Changes in Circulating Tumor DNA in Small Cell Lung Cancer.
Journal: JCO precision oncology
Published: December 18, 2025
Last Updated: 09/26/2026